Grantham, Mayo, Van Otterloo & Co (GMO)’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$257K Buy
+15,337
New +$257K ﹤0.01% 573
2024
Q4
Sell
-18,792
Closed -$339K 612
2024
Q3
$339K Sell
18,792
-2,036,723
-99% -$36.7M ﹤0.01% 516
2024
Q2
$33.4M Sell
2,055,515
-377,752
-16% -$6.14M 0.11% 123
2024
Q1
$34.3M Sell
2,433,267
-846,794
-26% -$11.9M 0.12% 119
2023
Q4
$34.2M Sell
3,280,061
-184,146
-5% -$1.92M 0.15% 119
2023
Q3
$35.3M Sell
3,464,207
-85,576
-2% -$873K 0.17% 110
2023
Q2
$26.7M Buy
3,549,783
+301,583
+9% +$2.27M 0.12% 149
2023
Q1
$28.7M Sell
3,248,200
-502,100
-13% -$4.44M 0.15% 146
2022
Q4
$34.2M Buy
3,750,300
+437,400
+13% +$3.99M 0.18% 119
2022
Q3
$26.7M Sell
3,312,900
-151,800
-4% -$1.23M 0.15% 133
2022
Q2
$26.1M Sell
3,464,700
-11,400
-0.3% -$85.7K 0.14% 156
2022
Q1
$32.6M Buy
3,476,100
+700,500
+25% +$6.58M 0.16% 110
2021
Q4
$22.2M Sell
2,775,600
-30,100
-1% -$241K 0.11% 158
2021
Q3
$27.3M Buy
2,805,700
+252,800
+10% +$2.46M 0.14% 130
2021
Q2
$25.3M Buy
2,552,900
+559,000
+28% +$5.53M 0.13% 136
2021
Q1
$23M Buy
1,993,900
+178,300
+10% +$2.06M 0.13% 131
2020
Q4
$17.5M Buy
+1,815,600
New +$17.5M 0.11% 130
2019
Q1
Sell
-15,000
Closed -$231K 739
2018
Q4
$231K Buy
+15,000
New +$231K ﹤0.01% 495
2018
Q3
Sell
-36,900
Closed -$897K 573
2018
Q2
$897K Buy
+36,900
New +$897K 0.01% 363
2017
Q1
Sell
-14,950
Closed -$542K 613
2016
Q4
$542K Sell
14,950
-321,750
-96% -$11.7M ﹤0.01% 376
2016
Q3
$15.5M Buy
336,700
+49,400
+17% +$2.27M 0.07% 174
2016
Q2
$14.4M Buy
+287,300
New +$14.4M 0.06% 197
2014
Q3
Sell
-11,400
Closed -$598K 476
2014
Q2
$598K Sell
11,400
-2,000
-15% -$105K ﹤0.01% 433
2014
Q1
$708K Buy
+13,400
New +$708K ﹤0.01% 496